Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Pharma
Asia
Drug Delivery
Executives
Clinical Data
Vaccines
Special Reports
Trending
COVID-19
Cell & Gene Therapy
Podcasts
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Subscribe
What are you searching for?
Enclose phrases in quotes. Use a + to require a term in results and - to exclude terms.
Example: +water -Europe
Subscribe
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Pharma
Asia
Drug Delivery
Executives
Clinical Data
Vaccines
Special Reports
Trending
COVID-19
Cell & Gene Therapy
Podcasts
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
FDA advisory committee
Pharma
FDA flags concerns about Ardelyx's kidney disease prospect
Ardelyx's problem, according to the FDA, is that tenapanor’s “magnitude of treatment effect appears less than that observed with approved drugs.”
Fraiser Kansteiner
Nov 15, 2022 10:48am
GSK's Zejula FDA oncology AdComm canceled
Nov 9, 2022 11:23am
GSK's daprodustat gets FDA adcomm yes, no votes in CKD
Oct 26, 2022 7:07pm
FDA outlines risks of GSK's daprodustat for panel to discuss
Oct 25, 2022 11:48am
Amylyx's ALS drug finally approved by FDA
Sep 29, 2022 5:00pm
FDA adcomm votes down Secura's PI3K drug in CLL
Sep 23, 2022 3:06pm